Navigation Links
Tecnalia develops environment-friendly and health-friendly pest control products
Date:10/20/2010

Tecnalia, through its Construction Unit, is participating in and coordinating a European FP7 research project for SMEs, called Bimosyn. The aim is to develop pest control products with lower concentrations of biocides and, thereby, be more environmentally friendly and less damaging for human health. The two years lasting project will be carried out jointly with the Swedish University of Agricultural Sciences (SLU) and five SME companies: Berkem (France), Linotech (Sweden), Rutlandbio (the United Kingdom), Quadrifolio (Portugal) and Dts-Oabe (Spain). These companies will be responsible for marketing the new products developed.

The scientific development of the project involves research into the degree of synergy between bioactive antioxidant substances (natural phenolic compounds, such as anthocyanins) and conventional insecticides and fungicides. The aim is to use natural, vegetable-origin extracts with the potential for being employed as biocide adjuvants for the chemical sector. In this way, pest control products which will have the same efficacy as conventional ones can be obtained and, at the same time, will not be prejudicial for the environment or to human health. The new pesticides will act to combat plague of flies, cockroaches, termites and wood-rotting fungi.

The project involves the study of the synergy between bioactive antioxidant molecules and synthetic biocides within the new European Biocide Products Directive 98/8/CE (BPD). The idea of this is to develop new pesticide product formulations which can be clearly differentiated in the market with respect to conventional, more contaminant pesticides. Other objectives of the project are to attain products which are competitive from a business and commercial perspective, as well as promoting the use of these pesticides in the construction sector.

Future challenges

Notable amongst the tasks to be undertaken is that the researchers will gather all the basic antioxidant materials, extracts of medicinal plants and biocides necessary for drawing up the project, with the aim of studying the synergic effects amongst them. The next step is drawing up various formulae with antioxidant or medicinal plant extracts mixed with biocides selected in the previous stage.

Then the efficacy of the different formulae will be evaluated with trials based on a number of European and international norms in matters of pest control. Finally, data on cost analysis will be obtained in order to help in reducing the price of the final product.


'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. UCLA develops combat casualty care educational program for US armed forces
2. Team led by LA BioMed scientist develops novel approach to study neurological disorders
3. Brain Develops Differently in Fragile X Syndrome
4. Olympus develops worlds fastest, most compatible endoscope reprocessor
5. Military develops multi-purpose green decontaminants for terrorist attack sites
6. How, When Child Develops Autism May Determine Outcomes
7. UMass Memorial health care develops fully integrated EMR
8. UD team develops new method for producing proteins critical to medical research
9. M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms
10. Personal Best Develops Workplace Weight Loss Program
11. Even Well-Controlled Diabetes May Present Post-Surgery Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV ... the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream ... Each week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors ...
(Date:2/5/2016)... CA (PRWEB) , ... February 05, 2016 , ... ... to announce the addition of micro-needling services in their Napa Valley office. The ... founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of ...
(Date:2/5/2016)... Miami, Florida (PRWEB) , ... February 05, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – is poised to once again host, Swirl, A Wine Tasting Event ...
(Date:2/5/2016)... ... February 05, 2016 , ... Regular gym users know the routine: ... wait longer to access the treadmills. It’s a predictable trend. After the excesses of ... and get in shape by joining gyms, starting new walking or running routines, or ...
(Date:2/5/2016)... , ... February 05, 2016 , ... At its annual ... Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds former ... the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat has ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016 Aethlon Medical, Inc. (Nasdaq: ... Chairman and CEO, will be presenting at Source Capital Group,s ... York, NY at 2:15 p.m. ET on Wednesday, ... Immunotherapy Panel discussion taking place at 3:15 p.m. ET. ... approximately one hour after the conclusion of the live event. ...
(Date:2/5/2016)... Feb. 5, 2016  Zimmer Biomet Holdings, Inc. (NYSE ... previously announced underwritten secondary offering of 11,027,558 shares of ... of affiliates of Blackstone and Goldman Sachs.  The shares ... price of $96.45 per share. The selling stockholders will ... Zimmer Biomet nor any of its directors, officers or ...
(Date:2/5/2016)... France , Germany ... and Israel ). It includes a 10-year epidemiology forecast ... segmented by age and sex in these markets. GD epidemiology report is ... in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends ... Germany , Italy , Spain ...
Breaking Medicine Technology: